These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 452004)

  • 1. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
    Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.
    Abe K; Yasujima M; Sakurai Y; Chiba S; Itoh T; Imai Y; Sato M; Haruyama T; Omata K; Goto T; Sato K; Hiwatari M; Otsuka Y; Yoshinaga K
    Jpn Circ J; 1979 Dec; 43(12):1105-16. PubMed ID: 396385
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
    Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres JA; Mancheño E; Millet VG; Sancho J; Rodicio JL
    Clin Exp Hypertens A; 1982; 4(6):989-1000. PubMed ID: 7047008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
    Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension.
    Abe K; Yasujima M; Irokawa N; Seino M; Chiba S; Sakurai Y; Sato M; Imai Y; Saito K; Ito T; Haruyama T; Otsuka Y; Yoshinaga K
    Clin Sci Mol Med Suppl; 1978 Dec; 4():363s-366s. PubMed ID: 282087
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man.
    Patak RV; Mookerjee BK; Bentzel CJ; Hysert PE; Babej M; Lee JB
    Prostaglandins; 1975 Oct; 10(4):649-59. PubMed ID: 1105697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term treatment with indomethacin on renal function.
    Ruilope LM; Garcia Robles R; Paya C; Alcazar JM; Miravalles E; Sancho-Rof J; Rodicio J; Knox FG; Romero JC
    Hypertension; 1986 Aug; 8(8):677-84. PubMed ID: 3525404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the mechanism of action of prostaglandin synthesis inhibitors on renin and aldosterone secretion and sodium excretion.
    Papanicolaou N; Papadakis G; Papanicolaou P; Theodorakopoulos P; Paris M; Dontas A; Paris M; Bariety J; Milliez P
    Prostaglandins Med; 1981 Aug; 7(2):163-81. PubMed ID: 6792644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dependence of plasma renin activity on protaglandin excretion in essential hypertension.
    Ylitalo P; Vapaatalo H; Metsä-Ketelä T; Pitkäjärvi T
    Acta Physiol Scand; 1978 Jan; 102(1):120-2. PubMed ID: 626085
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of the renin-aldosterone response to furosemide by indomethacin.
    Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1977 Jul; 45(1):174-6. PubMed ID: 874065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal kallikrein-kinin: its relation to renal prostaglandins and renin-angiotensin-aldosterone in man.
    Abe K; Sato M; Imai Y; Haruyama T; Sato K; Hiwatari M; Kasai Y; Yoshinaga K
    Kidney Int; 1981 Jun; 19(6):869-80. PubMed ID: 7021957
    [No Abstract]   [Full Text] [Related]  

  • 14. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension.
    Chiba S; Abe K; Yasujima M; Irokawa N; Saito K; Sakurai Y; Ito T; Sato M; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1979 Nov; 129(3):249-56. PubMed ID: 524352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
    Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K
    Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention.
    Frölich JC; Hollifield JW; Michelakis AM; Vesper BS; Wilson JP; Shand DG; Seyberth HJ; Frölich WH; Oates JA
    Circ Res; 1979 Jun; 44(6):781-7. PubMed ID: 218749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension.
    Abe K; Ito T; Sato M; Haruyama T; Sato K; Omata K; Hiwatari M; Sakurai Y; Imai Y; Yoshinaga K
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():141s-144s. PubMed ID: 7004721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostaglandin synthesis inhibitors on the renin-angiotensin system and renal function.
    Izumi Y; Franco-Saenz R; Mulrow PJ
    Hypertension; 1985; 7(5):791-6. PubMed ID: 3861577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S; Kobayashi M; Hashiba K
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.